Revvity | PKI - Ordinary Share Capital


Revvity reported $111.63M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Agilent USD 281.97M 252K Jun/2026
Align Technology USD 71.62M 1000 Jun/2026
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Bruker USD 152.35M 130K Jun/2026
Celltrion KRW 228.57M 1.08M Jun/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Danaher USD 703.4M 500K Sep/2026
Dentsply International USD 199.2M 1.1M Jun/2026
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Illumina USD 151.3M 607K Jun/2026
Intuitive Surgical USD 353.28M 885K Sep/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Kangmei Pharma CNY 13.83B 0 Jun/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Laboratory Of America USD 80.9M 1.4M Jun/2026
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Organigram Holdings CAD 136.47M 1.34M Mar/2026
Ovoca Bio EUR 29.49M 0 Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Pharma Mar EUR 17.34M 24.24K Jun/2026
Qiagen NV USD 206.5M 245K Jun/2026
Quest Diagnostics USD 110M 0 Sep/2026
Quidel USD 68.1M 200K Mar/2026
Repligen USD 56.43M 28K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Sartorius EUR 69.05M 0 Sep/2026
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
Tilray USD 116.52M 5.01M Sep/2025
Waters USD 98.19M 20K Jun/2026
Zealand Pharma A/S 70.66M 53K Mar/2026
Zz Pientze Pharmaceu CNY 603.32M 0 Jun/2026